儿童临床试验未完成相关研究因素:欧洲临床试验数据库回顾分析及欧洲地区启示
该研究基于欧洲临床试验数据库2014至2018年注册的含18岁以下患者的临床试验,将试验分为「所有病例完成」与「未所有病例完成」两组,采用逻辑回归分析未完成的相关因素。共分析142项试验(95项完成、47项未完成),发现试验开展国家数量是唯一显著因素(OR 1.3,95%CI 1.1-1.5)。结论提示试验前需考虑开展国家的可行性。
要点
- 试验开展国家数量是儿童临床试验未完成的唯一显著相关因素。
- 共分析142项试验,其中47项未在所有参与国家完成。
- 试验启动前应评估开展国家的可行性。
核心结论
- 试验开展国家数量是含儿童患者临床试验出现「未所有病例完成」的唯一显著因素。
- 建议在试验前考虑开展国家的可行性。
研究设计与样本
- 共分析142项临床试验,其中95项为「所有病例完成」,47项为「未所有病例完成」。
- 采用逻辑回归分析计算比值比和95%置信区间。
主要发现
- 逻辑回归显示试验开展国家数量是唯一显著因素(OR 1.3,95%CI 1.1-1.5)。
临床怎么用
- 在启动含儿童患者的临床试验前,应评估拟开展国家的可行性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incomplete clinical trials for pediatric drug development result in a lack of adequate scientific evidence for providing appropriate medication to pediatric populations; this is especially true for Japan. Thus, using the European Clinical Trials Database (EudraCT), this study aimed to identify the factors related to the study design and administration that lead to incompletion of clinical trials that included pediatric patients. METHODS: We focused on clinical trials that included patients under the age of 18 registered in the database, named as the European Clinical Trials Database between January 1, 2014, and December 31, 2018. Two groups of trials were identified: "all cases completed" and "not all cases completed," reflecting whether they were completed in all participating countries/regions or not. To identify the factors of the occurrence of "not all cases completed," a logistic regression analysis was performed to calculate the odds ratios and 95% confidence intervals. In total, 142 clinical trials (95 "all cases completed" and 47 "not all cases completed") were analyzed. RESULTS: The logistic regression analysis showed the number of countries in which a clinical trial was conducted to be the only significant factor (odds ratio: 1.3; 95% confidence interval: 1.1-1.5); this was identified as the primary factor for the occurrence of "not all cases completed" in the clinical trials that included pediatric patients. CONCLUSION: Our findings suggest that the feasibility of clinical trials that include pediatric patients, such as whether the countries in which the trial is to be conducted are suitable, must be considered prior to the trial.
引用
- Tanemura N, Sasaki T, Sato J, et al. Study factors associated with the incompletion of clinical trials that include pediatric patients: a retrospective analysis of the European Clinical Trials Database and a lesson from the European region. Trials. 2021. PMID: 33706800. doi:10.1186/s13063-021-05143-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。